|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CURRENT ASSETS: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Marketable equity securities, at fair value | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Crypto assets, at fair value | ||||||||||||||||||||
| Deferred offering costs | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| NON-CURRENT ASSETS: | ||||||||||||||||||||
| Crypto assets, at fair value | ||||||||||||||||||||
| Prepaid expenses and other assets, net of current portion | ||||||||||||||||||||
| Operating lease right-of-use asset, net | ||||||||||||||||||||
| Investment in joint ventures at fair value | ||||||||||||||||||||
| Total Non-Current Assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| CURRENT LIABILITIES: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Operating lease liability, current portion | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Operating lease liability, less current portion | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| STOCKHOLDERS’ EQUITY: | ||||||||||||||||||||
| Common stock, $0.0001 par value; 50,000,000 shares authorized; 23,184,634 and 15,514,312 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Total Stockholders’ Equity | ||||||||||||||||||||
| Total Liabilities and Stockholders’ Equity | ||||||||||||||||||||
Loading...
